Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients

Diabetes management during Ramadan fasting is challenging to the physician in terms of minimizing the risk of hypoglycemia. As compared to oral hypoglycemic agents (OHAs) and sulfonylureas (SUs), which carry a higher and significant risk of hypoglycemia, newer antidiabetic agents such as dipeptidyl...

Descripción completa

Detalles Bibliográficos
Autor principal: Aziz, Kamran MA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404947/
https://www.ncbi.nlm.nih.gov/pubmed/25931826
http://dx.doi.org/10.2147/DMSO.S54683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404947/
https://www.ncbi.nlm.nih.gov/pubmed/25931826
http://dx.doi.org/10.2147/DMSO.S54683

Ejemplares similares